Drake & Associates’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,469
Closed -$260K 70
2022
Q3
$260K Buy
1,469
+260
+22% +$51.4K 0.15% 48
2022
Q2
$247K Buy
+1,209
New +$256K 0.14% 50

Other funds holding CME

Drake & Associates's CME Position: Q4 2022 in Review

Drake & Associates sold out of CME Group (CME) in Q4 2022, closing a stake of 1,469 shares — an estimated $260K sold.

Drake & Associates first reported a position in CME in Q2 2022 and held it in 2 quarters. The position peaked at $260K in Q3 2022. 1,149 funds tracked by Wall St. Rank hold CME as of Q4 2022.

  • Drake & Associates reported no remaining CME Group position as of Q4 2022 after selling out during the quarter.
  • Drake & Associates sold 1,469 CME Group shares in Q4 2022, an estimated $260K.
  • Drake & Associates first reported a position in CME Group in Q2 2022 and held it in 2 quarters.
  • Drake & Associates's CME Group position peaked at $260K in Q3 2022.
  • 1,149 funds tracked by Wall St. Rank held CME Group as of Q4 2022.

Based on Drake & Associates's 13F filing for Q4 2022, filed 17 Jan 2023.